Scinai Immunotherapeutics Ltd (SCNI) — Net Asset Quality Index
Scinai Immunotherapeutics Ltd (SCNI) has a Net Asset Quality Index of 66.4% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $11.84 Million minus total liabilities of $3.98 Million yields net assets of $7.86 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check SCNI cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Scinai Immunotherapeutics Ltd Net Asset Quality Index Over Time (2000–2024)
This chart shows how Scinai Immunotherapeutics Ltd's Net Asset Quality Index has evolved across 25 annual periods from 2000 to 2024. As of June 2025, the index stands at 66.4%, representing net assets of $7.86 Million against total assets of $11.84 Million USD. See Scinai Immunotherapeutics Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Scinai Immunotherapeutics Ltd (2000–2024)
The table below presents the year-by-year Net Asset Quality Index for Scinai Immunotherapeutics Ltd from 2000 to 2024, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see SCNI stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 74.2% | $9.98 Million | $13.45 Million | $3.47 Million | ▲ +100.3 pp |
| 2023 | -26.2% | $-4.57 Million | $17.47 Million | $22.04 Million | ▼ -19.6 pp |
| 2022 | -6.5% | $-1.76 Million | $27.07 Million | $28.83 Million | ▼ -9.6 pp |
| 2021 | 3.1% | $982.00K | $32.04 Million | $31.05 Million | ▲ +28.7 pp |
| 2020 | -25.6% | $-4.54 Million | $17.71 Million | $22.25 Million | ▲ +30.6 pp |
| 2019 | -56.2% | $-18.84 Million | $33.52 Million | $52.36 Million | ▼ -26.7 pp |
| 2018 | -29.5% | $-8.35 Million | $28.30 Million | $36.65 Million | ▼ -98.3 pp |
| 2017 | 68.9% | $16.17 Million | $23.48 Million | $7.31 Million | ▼ -16.2 pp |
| 2016 | 85.1% | $6.65 Million | $7.82 Million | $1.17 Million | ▲ +3.9 pp |
| 2015 | 81.2% | $8.61 Million | $10.60 Million | $1.99 Million | ▼ -8.6 pp |
| 2014 | 89.8% | $4.26 Million | $4.74 Million | $481.23K | ▼ -3.0 pp |
| 2013 | 92.9% | $6.92 Million | $7.45 Million | $529.76K | ▼ -2.7 pp |
| 2012 | 95.6% | $5.95 Million | $6.22 Million | $272.58K | ▲ +1.9 pp |
| 2011 | 93.7% | $6.71 Million | $7.16 Million | $450.86K | ▲ +2.3 pp |
| 2010 | 91.5% | $7.94 Million | $8.68 Million | $742.07K | ▼ -2.8 pp |
| 2009 | 94.3% | $8.44 Million | $8.95 Million | $512.67K | ▲ +0.5 pp |
| 2008 | 93.8% | $3.00 Million | $3.20 Million | $197.78K | ▲ +653.8 pp |
| 2007 | -560.0% | $-3.31 Million | $592.00K | $3.91 Million | ▼ -647.9 pp |
| 2006 | 87.9% | $1.74 Million | $1.98 Million | $240.00K | ▲ +7.1 pp |
| 2005 | 80.8% | $2.70 Million | $3.35 Million | $643.00K | ▲ +1.1 pp |
| 2004 | 79.7% | $4.11 Million | $5.15 Million | $1.04 Million | ▲ +53.2 pp |
| 2003 | 26.5% | $648.00K | $2.44 Million | $1.80 Million | ▲ +21.2 pp |
| 2002 | 5.3% | $90.00K | $1.70 Million | $1.61 Million | ▲ +405.3 pp |
| 2001 | -400.0% | $-4.00K | $1.00K | $5.00K | ▲ +400.0 pp |
| 2000 | -800.0% | $-24.00K | $3.00K | $27.00K | — |